Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers | Zendy

Neal L. Benowitz | Zendy; Andrew Pipe | Zendy; Robert West | Zendy; J. Taylor Hays | Zendy; Serena Tonstad | Zendy; Thomas McRae | Zendy; David Lawrence | Zendy; Lisa St Aubin | Zendy; Robert M. Anthenelli | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers

Author(s) -

Neal L. Benowitz,

Andrew Pipe,

Robert West,

J. Taylor Hays,

Serena Tonstad,

Thomas McRae,

David Lawrence,

Lisa St Aubin,

Robert M. Anthenelli

Publication year - 2018

Publication title -

jama internal medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.14

H-Index - 342

eISSN - 2168-6114

pISSN - 2168-6106

DOI - 10.1001/jamainternmed.2018.0397

Subject(s) - medicine , mace , nicotine patch , nicotine replacement therapy , myocardial infarction , smoking cessation , varenicline , randomized controlled trial , adverse effect , bupropion , physical therapy , nicotine , placebo , anesthesia , percutaneous coronary intervention , alternative medicine , pathology

Quitting smoking is enhanced by the use of pharmacotherapies, but concerns have been raised regarding the cardiovascular safety of such medications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research